RXO RXO

RXO FY 2024: revenue $4.5B, up 16%; diluted EPS −$2.17

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers RXO reported for the year ended Dec 31, 2024, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$4.5B+16% from $3.9B in FY 202310-K income statement, on EDGAR
  2. Net income−$290.0M−7350% from $4.0M in FY 202310-K income statement, on EDGAR
  3. Diluted EPS−$2.17−7333% from $0.03 in FY 202310-K income statement, on EDGAR
  4. Cash and cash equivalents$35.0M+600% from $5.0M in FY 202310-K balance sheet, on EDGAR
  5. Cash from operations−$12.0M−113% from $89.0M in FY 202310-K cash flow statement, on EDGAR

Every year in the financial tables

Get an email when RXO files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 4700 and related industry codes: the same peer list as the financial tables.